Elevated Plasma MMP1 and MMP9 are Associated with Abdominal Aortic Aneurysm Rupture

European Journal of Vascular and Endovascular Surgery

Volumn 35, Issue 5, 2008, Pages 580-584

  Wilson, W R W ^a   Anderton, M ^a   Choke, E C ^b   Dawson, J ^b   Loftus, I M ^b   Thompson, M M ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Abdominal aortic aneurysm; Matrix metalloproteinase; Rupture

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ABDOMINAL AORTA ANEURYSM; AGED; ANEURYSM RUPTURE; ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOGENESIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL TECHNIQUE; SURVIVAL;

AGED; AGED, 80 AND OVER; ANEURYSM, RUPTURED; AORTIC ANEURYSM, ABDOMINAL; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 41549130789     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2007.12.004     Document Type: Article

References (19)

1. EVAR Trial Participants. Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet 365 9478 (2005) 2179-2186
2. UK Small Aneurysm Trial Participants. Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 346 19 (2002) 1445-1452
3. Bown M.J., Sutton A.J., Bell P.R., and Sayers R.D. A meta-analysis of 50 years of ruptured abdominal aortic aneurysm repair. Br J Surg 89 6 (2002) 714-730
4. Pearce W.H., and Shively V.P. Abdominal aortic aneurysm as a complex multifactorial disease: interactions of polymorphisms of inflammatory genes, features of autoimmunity, and current status of MMPs. Ann N Y Acad of Sci 1085 (2006) 117-132
5. Lindholt J.S., Vammen S., Fasting H., Henneberg E.W., and Heickendorff L. The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur J Vasc Endovasc Surg 20 3 (2000) 281-285
6. Sangiorgi G., D'Averio R., Mauriello A., Bondio M., Pontillo M., Castelvecchio S., et al. Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Circulation 104 12 Suppl. 1 (2001) I288-I295
7. Wilson W.R., Anderton M., Schwalbe E.C., Jones J.L., Furness P.N., Bell P.R., et al. Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture. Circulation 113 3 (2006) 438-445
8. Longo G.M., Xiong W., Greiner T.C., Zhao Y., Fiotti N., and Baxter B.T. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110 5 (2002) 625-632
9. McMillan W.D., and Pearce W.H. Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg 29 1 (1999) 122-127
10. Hovsepian D.M., Ziporin S.J., Sakurai M.K., Lee J.K., Curci J.A., and Thompson R.W. Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease. J Vasc Interv Radiol 11 10 (2000) 1345-1352
11. Petersen E., Wagberg F., and Angquist K.A. Proteolysis of the abdominal aortic aneurysm wall and the association with rupture. Eur J Vasc Endovasc Surg 23 2 (2002) 153-157
12. Watanabe T., Sato A., Sawai T., Uzuki M., Goto H., Yamashita H., et al. The elevated level of circulating matrix metalloproteinase-9 in patients with abdominal aortic aneurysms decreased to levels equal to those of healthy controls after an aortic repair. Ann Vasc Surg 20 3 (2006) 317-321
13. Davis V., Persidskaia R., Baca-Regen L., Itoh Y., Nagase H., Persidsky Y., et al. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 18 10 (1998) 1625-1633
14. Patel M.I., Melrose J., Ghosh P., and Appleberg M. Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg 24 1 (1996) 82-92
15. Alvarez B., Ruiz C., Chacon P., Alvarez-Sabin J., and Matas M. Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis. J Vasc Surg 40 3 (2004) 469-475
16. Shu J., Ren N., Du J.B., Zhang M., Cong H.L., and Huang T.G. Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndrome. Scand Cardiovasc J 41 3 (2007) 149-154
17. Hoffmann U., Bertsch T., Dvortsak E., Liebetrau C., Lang S., Liebe V., et al. Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis. Scand J Infect Dis 38 10 (2006) 867-872
18. Yassen K.A., Galley H.F., and Webster N.R. Matrix metalloproteinase-9 concentrations in critically ill patients. Anaesthesia 56 8 (2001) 729-732
19. Nakamura T., Ebihara I., Shimada N., Shoji H., and Koide H. Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septick shock: effect of fiber-immobilized polymyxin B treatment. American Journal of Medical Sciences 316 6 (1998) 355-360